Healthcare works best when the right knowledge reaches the right person at the right moment. Yet for many clinicians, that ideal remains frustratingly out of reach. Information is scattered across systems that do not speak to each other. Processes built for an earlier era slow down decisions that cannot afford to wait. And the professionals most committed to their patients often find themselves spending more time navigating administrative complexity than actually caring for people.
The clinicians who push back against this reality are not simply critics of the system. They are the ones who stay in it long enough to understand exactly where it breaks down, and then dedicate themselves to building something better. That kind of work requires patience, clinical credibility, and a genuine understanding of what healthcare professionals actually need.
Dr. Mohammed As’ad, Physician, Health Tech and AI Visionary, and Advocate for Quality and Patient Safety at Dr. Sulaiman Al Habib Medical Group, has spent nearly three decades doing exactly that. His career across emergency medicine, surgery, quality improvement, and digital innovation has been shaped by one consistent question: how can the systems surrounding clinicians be made good enough to match the commitment of the people working within them?
Let’s explore how Dr. Mohammed As’ad is shaping the future of healthcare through responsible AI and digital innovation!
A Journey Driven by Healthcare Challenges
Dr. Mohammed’s professional journey spans nearly three decades across emergency medicine, surgery, healthcare quality, patient safety, research, and digital innovation. Working in acute and emergency care exposed him to healthcare at its most demanding, where decisions are made under uncertainty, information is fragmented, risks are time-sensitive, and healthcare professionals must navigate increasingly complex systems.
Over time, he became increasingly interested in why capable and committed clinicians sometimes struggle to deliver optimal care. He explains that the issue is not a lack of knowledge or effort. It is the system surrounding the clinician: inaccessible evidence, delayed communication, inefficient processes, fragmented technologies, unclear responsibilities, or poorly coordinated care.
This understanding led him towards quality improvement and patient safety, where he became involved in analysing risk, redesigning clinical pathways, measuring outcomes, and supporting improvement across complex healthcare services. His interest in artificial intelligence and healthcare technology developed naturally from this work.
Instead of viewing technology as an independent discipline, he began to see it as another means of solving problems involving knowledge access, decision support, medication safety, communication, coordination, and chronic disease management.
At the heart of his work is a philosophy that continues to guide every initiative he undertakes. His approach always begins with the healthcare problem rather than the technology itself. He first seeks to understand the need, the system that produces it, and the people affected by it. Only then does he consider how artificial intelligence or digital technology might provide a practical, responsible, and scalable response.
Keeping Innovation Connected to Patient Care
For Dr. Mohammed, clinical practice has always shaped the way he designs and evaluates healthcare technology. He believes technology must function under real clinical conditions rather than perform well only during demonstrations or controlled testing. A platform may appear technically impressive, yet fail when introduced into a busy emergency department, operating theatre, intensive care unit, hospital ward, pharmacy, or outpatient service
Emergency medicine was particularly influential because it requires decisions under uncertainty, often with incomplete information and limited time. These realities strengthened his interest in technologies that make reliable knowledge easier to retrieve, organise complex information, reduce unnecessary delays, and support professional judgement.
At the same time, his patient-safety experience has made him equally aware of the risks technology can introduce. Poorly designed systems may increase cognitive burden, generate excessive alerts, fragment information, or encourage users to trust automated outputs without adequate scrutiny.
As a result, he evaluates every healthcare technology through a series of practical questions: Does it address a meaningful problem? Does it fit the actual workflow? Is its output understandable and verifiable? Does it reduce or increase professional workload? How will errors be detected? What happens when the technology is unavailable? Above all, does it strengthen human decision-making rather than replace it uncritically?
Clinical experience, he believes, keeps innovation connected to patient care, while quality improvement and patient safety ensure that technologies are tested carefully and potential failures are considered from the beginning.
Building Technology Around Meaningful Healthcare Problems
One principle consistently guides Dr. Mohammed’s work: meaningful healthcare innovation begins by understanding the problem before designing the solution.
This philosophy has shaped several digital initiatives, each created to address a different healthcare challenge while sharing a common objective: making healthcare knowledge, information, communication, and intelligence more accessible and useful.
As he explains, “Each initiative arose from a different problem, yet together they form a connected innovation portfolio.”
He explains that Fahrasah was developed in response to the difficulty clinicians, researchers, and students experience when navigating the rapidly expanding scientific literature. Although relevant knowledge exists, discovering and organising it can be challenging, particularly when users understand the concept they are investigating but do not know the exact terminology used in titles, abstracts, or indexing systems.
He also developed EthraMed to address another critical challenge by improving access to structured medication information and safety intelligence. Drug information is often dispersed across regulatory sources, databases, and reference systems, making efficient access difficult. The platform brings together medication information, interaction checking, organ-system effects, regional information, and safety alerts in a more accessible and organised form.
Meanwhile, Ejtame emerged from the need for flexible digital communication and collaboration infrastructure. Now progressing through its user testing and review phase, the platform continues to evolve through user assessment of its functionality, usability, reliability, and areas requiring refinement before wider release.
He is also leading the AI-based Diabetes Center, an ongoing research and development project exploring how clinical evidence, longitudinal health data, validated algorithms, predictive modelling, and personalised analytics might support a more integrated understanding of diabetes management.
Together, these initiatives form a connected innovation portfolio addressing scholarly discovery, medication intelligence, digital communication, and the future potential of personalised care.
Making Knowledge More Accessible Through Fahrasah
Among Dr. Mohammed’s initiatives, Fahrasah reflects one of his strongest beliefs about artificial intelligence in healthcare.
Developed as an AI-powered scholarly search platform, Fahrasah helps clinicians, researchers, students, and other users discover healthcare evidence more effectively. As scientific literature continues to expand, conventional keyword searching often depends on knowing the precise language used by authors and databases, even when users understand the concept they are investigating.
Fahrasah uses semantic and hybrid search approaches to connect a user’s intended meaning with relevant literature while supporting structured and Boolean searching, research screening, open-access discovery, and export of results for further analysis.
He emphasises that the platform is not intended to replace established bibliographic databases, professional librarians, or the rigorous methods required for systematic reviews. Instead, it seeks to reduce barriers to discovering and working with scholarly evidence.
Reflecting his broader philosophy, he explains that “Some of its most valuable applications may not involve replacing human expertise. AI can help people navigate complexity, reduce the time required to find relevant information, and make existing knowledge more accessible.”
Fahrasah also represents his belief that researchers and healthcare professionals in the Middle East should not remain solely consumers of technologies developed elsewhere. They should also contribute to designing platforms that respond to their own academic, linguistic, and professional environments.
This vision continues to shape not only Fahrasah but also the broader direction of his work, developing technologies that solve genuine healthcare problems while strengthening regional innovation capabilities.
Advancing Medication Intelligence Through EthraMed
For Dr. Mohammed, meaningful innovation is not always about creating new medical knowledge. In many cases, it is about making reliable knowledge easier to access, organise, and apply responsibly. This philosophy underpins EthraMed, a medication-information and regulatory-intelligence platform designed to improve access to structured medication information while supporting medication safety.
He explains that currently in beta and under active development and testing, EthraMed is being evaluated by test users and subject-matter reviewers who are assessing its content, functionality, usability, and reliability. Their feedback continues to guide correction and further development, and the platform has not yet been validated for clinical decision-making.
Medication safety is inherently complex. Clinicians, pharmacists, patients, researchers, and healthcare organisations often need access to drug interactions, adverse effects, safety warnings, regulatory information, and organ-system effects. Since this information is frequently dispersed across multiple sources, efficient access can be challenging.
To address this, EthraMed provides a unified interface for searching medications, reviewing potential drug interactions, examining organ-related effects, accessing regional information, and following medication safety alerts. Its planned application programming interface may eventually enable structured, source-referenced medication information to be integrated into healthcare platforms, hospital systems, pharmacy applications, and research workflows.
At the same time, he clearly defines the platform’s role. EthraMed is intended as an informational and professional-support resource, not as an autonomous prescribing system or a substitute for qualified clinical judgement. During the testing phase, its outputs should be verified against authoritative sources, as medication decisions require consideration of diagnosis, dose, age, organ function, allergies, pregnancy status, laboratory findings, concurrent treatment, and other patient-specific factors.
Ultimately, EthraMed demonstrates that healthcare innovation does not always require creating entirely new medical knowledge. As he highlights, innovation may also involve organising reliable information more effectively, improving accessibility, and building infrastructure through which medication intelligence can eventually support wider healthcare, pharmacy, and research systems.
Strengthening Communication Through Ejtame
Alongside knowledge and medication intelligence, Dr. Mohammed recognises that effective communication is fundamental to modern healthcare. This understanding inspired Ejtame, a digital communication and collaboration platform currently progressing through a user testing and review phase.
He explains that having moved beyond its initial development, the platform is now being evaluated for its functionality, usability, reliability, user experience, and areas requiring further refinement. Feedback from this phase continues to guide technical and design improvements before wider release.
He adds that although Ejtame is not limited exclusively to healthcare, its development has been strongly influenced by healthcare environments, where communication, coordination, privacy, reliability, accessibility, and continuity are essential.
Modern healthcare organisations depend heavily on digital communication for multidisciplinary collaboration, education, remote support, and coordination across different locations. However, many organisations rely largely on a small number of global platforms, limiting control over infrastructure, customisation, cost, and future service design.
Through Ejtame, he explores how communication infrastructure might be developed with greater flexibility, scalability, security, and regional relevance. Beyond the platform itself, it reflects a broader belief that professionals in the region should move beyond identifying gaps in existing technologies and actively participate in designing, building, testing, and refining alternatives.
As he notes, “The platform’s ultimate value will not be determined by the number of features it contains, but by whether it provides a reliable, useful, and sustainable communication experience for its intended users.”
Exploring the Future of Personalised Diabetes Care
Dr. Mohammed’s commitment to addressing complex healthcare challenges also extends to chronic disease management. He is leading the AI-based Diabetes Center, an ongoing research and development project exploring how evidence, longitudinal health information, validated algorithms, and predictive analytics might support more personalised diabetes management.
He believes diabetes cannot be understood through a single laboratory result or isolated consultation. Effective management requires consideration of multiple interacting factors, including glucose patterns, glycated haemoglobin, medications, weight, cardiovascular risk, renal function, complications, lifestyle, treatment tolerance, and personal goals.
The project is exploring two complementary capabilities. The first is an evidence-based support layer that organises relevant clinical information and established recommendations. The second is a predictive and personalisation layer investigating whether patterns within longitudinal data can help identify risks, likely responses, or future care priorities.
Importantly, the project remains developmental. It is not currently a validated medical device, an autonomous treatment system, or a replacement for an endocrinologist or other qualified healthcare professional.
Instead, its purpose is to investigate how artificial intelligence might support clinicians and patients by synthesising complex information, identifying potentially meaningful patterns, and strengthening continuity of understanding over time.
Throughout the project, human oversight remains fundamental. Validation, transparency, privacy protection, information security, clear governance, and defined accountability are essential. As he emphasises, the objective is not to remove the clinician from decision-making but to provide better-organised information through which professional judgement may be exercised.
Redefining What Meaningful Innovation Looks Like
As artificial intelligence continues to advance, Dr. Mohammed believes it is becoming increasingly important to distinguish meaningful innovation from technology that is merely impressive.
For him, “Meaningful innovation always begins with a clearly defined problem.” Technology that is sophisticated but disconnected from a genuine need may attract attention without producing lasting value.
He evaluates healthcare innovation according to several principles. It should address a relevant problem, improve an outcome or capability, fit the environment in which it will be used, avoid creating disproportionate burden or risk, and demonstrate measurable value.
He also draws an important distinction between introducing technology and transforming a healthcare system. Installing an application, algorithm, or digital platform does not automatically improve care. The surrounding processes, responsibilities, training, governance arrangements, and professional behaviours must also change.
Healthcare organisations, he observes, sometimes confuse implementation with impact. A product may be introduced and training completed without demonstrating meaningful improvements in patient care, professional capability, or operational performance.
Equally important is sustainability. Some innovations perform well during pilot programmes because they receive additional attention, staffing, resources, or leadership support. Their true value becomes apparent only when they continue to function effectively during routine operations.
As he explains, “The strongest innovations are not necessarily those using the most advanced technology. They are those that become useful, reliable, safe, understandable, and sufficiently integrated into real work to create value that persists.”
This philosophy continues to guide every initiative within his innovation portfolio, ensuring that technology remains firmly connected to clinical reality, patient safety, and meaningful long-term impact.
Ensuring Safe and Responsible AI in Healthcare
For Dr. Mohammed, developing healthcare AI extends well beyond technical performance. While accuracy remains important, he believes it represents only one part of a much broader evaluation.
A model may perform well within a controlled dataset but behave differently when applied to another population, clinical setting, workflow, or data source. For this reason, healthcare AI should not be evaluated only through technical accuracy.
His background in quality improvement and patient safety has shaped a comprehensive approach to governance. Quality improvement contributes methods for understanding processes, testing interventions, measuring outcomes, and identifying unintended consequences. Patient safety, meanwhile, brings attention to human factors, failure modes, automation bias, escalation, accountability, and system resilience.
In practice, this means AI systems must be evaluated at several levels. The technical model should be assessed, but so should the data on which it depends, the way results are displayed, the decisions influenced by those results, and the eventual effects on patients and professionals.
Human oversight, he stresses, must be meaningful rather than symbolic. Simply stating that a clinician remains responsible is not sufficient if the system itself encourages automatic acceptance of its outputs. Professionals need to understand what the technology can and cannot do, the source and limitations of its information, and when its recommendations should be questioned.
Building on this, He believes healthcare AI governance should involve clinicians, quality and patient-safety professionals, data scientists, technology teams, cybersecurity specialists, operational leaders, legal and regulatory expertise, and patients where appropriate. Ultimately, the relevant question is not merely whether an AI system works. It is whether it improves care safely, reliably, transparently, and equitably in the environment where it will actually be used.
Building Regional Healthcare Technology Capability
As healthcare transformation accelerates across the Middle East, Dr. Mohammed believes the region’s future success will depend not only on adopting advanced technologies but also on developing the ability to understand, validate, govern, adapt, and create them.
He explains that healthcare systems in the region have unique populations, languages, service models, regulatory environments, economic conditions, and cultural expectations. While technologies developed elsewhere can provide significant value, they should not always be adopted without local evaluation and adaptation.
Developing regional capability also carries strategic importance. Heavy dependency on external platforms, models, infrastructure providers, or proprietary datasets may create operational vulnerabilities. Organisations must consider what happens when access changes, costs increase, services are interrupted, or externally developed systems do not adequately represent local populations and priorities.
For him, building regional technology does not mean rejecting international collaboration. Instead, it enables the region to participate in global innovation with greater confidence and capability.
Fahrasah, EthraMed, Ejtame, and the AI-based Diabetes Center represent this broader direction. He believes these initiatives demonstrate that healthcare professionals in the Middle East can move beyond being users and evaluators of technology to becoming active contributors in originating, designing, testing, and building solutions.
Turning Healthcare Ideas into Sustainable Solutions
While innovation begins with identifying meaningful problems, transforming those ideas into operational solutions requires overcoming significant challenges.
One of the greatest challenges, according to Dr. Mohammed, is moving from recognising a healthcare opportunity to creating a functional and sustainable product.
A valuable clinical idea is only the starting point. Building technology around it requires multidisciplinary expertise across software architecture, infrastructure, privacy, cybersecurity, regulation, user experience, validation, scalability, cost, maintenance, and long-term sustainability.
A clinically valuable solution may fail if these elements are overlooked. Similarly, a technically successful product may struggle if it does not align with user needs or existing workflows.
Another important challenge for him is maintaining the balance between ambition and evidence. Artificial intelligence is developing rapidly, creating pressure for bold claims and quick adoption. However, healthcare requires discipline and responsibility. It is essential to distinguish between an idea, a research project, a platform undergoing testing, an operational resource, and a validated clinical product.
His innovation journey has also taken place alongside clinical practice, corporate quality and patient-safety responsibilities, research, and other professional commitments. Progress has required persistence, prioritisation, and continuous learning across disciplines beyond traditional medical training.
Yet, building products has provided valuable insights that cannot be gained through theory alone. It reveals the difference between an idea and a practical solution while creating a deeper understanding of what successful innovation truly requires.
A Future Built on Responsible Artificial Intelligence
Looking ahead, Dr. Mohammed remains committed to developing practical technologies that improve access to knowledge, strengthen medication safety, support healthcare decisions, enable communication, and contribute to regional digital capability.
His vision includes further developing Fahrasah as a scholarly search and research-support platform, expanding EthraMed as a structured medication-information and regulatory-intelligence resource, refining Ejtame through its ongoing user testing phase, and continuing research and development for the AI-based Diabetes Center.
Beyond these individual initiatives, his focus extends to the wider relationship between artificial intelligence, healthcare systems, professional capability, and digital sovereignty.
For him, the future of healthcare AI should not be defined only by larger models, increased automation, or greater computing power. It should also be shaped by trustworthiness, clinical relevance, transparency, local adaptation, and measurable value.
He believes clinicians and healthcare leaders should contribute not only as users, purchasers, or evaluators of technology but also as originators, designers, researchers, and builders.
At the centre of his work is a commitment to translating clinical experience, scientific evidence, systems thinking, and technological capability into solutions that are useful, responsible, and capable of creating meaningful value.
As he concludes, “Technology should not distance healthcare from its human purpose. At its best, it should make knowledge more accessible, decisions better informed, systems more reliable, and care more responsive to the people it is intended to serve.”
Through this approach, Dr. Mohammed As’ad represents a new generation of healthcare leaders, those who understand that the true promise of artificial intelligence lies not in replacing human expertise but in strengthening it. By bringing together clinical experience, patient safety, and responsible innovation, he continues to shape a future where technology becomes a trusted partner in delivering safer, smarter, and more human-centred healthcare.
